RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Gramercy Surgery Center and CivaTech Oncology are proud to announce their partnership to form the first-of-its-kind Center of Excellence—a regional flagship care provider and training site for CivaString and CivaSheet brachytherapy technology. The Center will be based at of Gramercy Surgery Center in Manhattan as well as its brand new 11,000 sq. ft. ambulatory surgery center in Flushing, Queens, which is slated to open its doors and perform its first operation later this month.
Dedicated to innovation in low dose rate radioisotopes for treating cancer, CivaTech Oncology has chosen Gramercy Surgery Center for its longstanding commitment to training, research, and excellence in providing consistent, high-quality, and cost-effective medical care. Gramercy Surgery Center has continually demonstrated quality and innovation in healthcare since 2007, when it became the first freestanding ambulatory surgery center in New York State and one of the first in the entire nation to perform brachytherapy in an outpatient setting.
Together, CivaTech and Gramercy’s Center of Excellence will allow for in-depth training on the use of CivaTech products, provide research opportunities, and patient treatment utilizing CivaTech’s FDA cleared brachytherapy technology. CivaTech products replace metal implants with cutting edge polymer encapsulated sources - made with new, modern materials.
“We are proud to partner with Gramercy Healthcare” said Suzanne Babcock, CivaTech CEO. “CivaTech and Gramercy share a vision of providing practical and convenient methods to treat cancer with minimal side effects and improved patient outcomes.”
For more information or any questions regarding the Center of Excellence established by CivaTech Oncology and Gramercy Surgery Center, please contact
